Alzheimer” An Ambiguous Ailment; A Comprehensive Review

Authors

  • Mallesh M. Department of Pharmacy Practice, P. Rami Reddy Memorial College of Pharmacy, Kadapa, A.P–516003, India
  • S. Asma Umira Department of Pharmacy Practice, P. Rami Reddy Memorial College of Pharmacy, Kadapa, A.P–516003, India
  • Purushothama Reddy K. Department of Pharmacy Practice, P. Rami Reddy Memorial College of Pharmacy, Kadapa, A.P–516003, India

DOI:

https://doi.org/10.37591/(rrjops).v5i3.527

Abstract

 

Alzheimer Disease (AD) is a gradually progressive dementia affecting cognition, behavior, and functional status. It was discovered a century back (1907) characterized by defects in language use, visual-spatial perception, ability to learn, solve problems, perform mathematical calculations, thinking abstractly, and making appropriate judgments, affecting more than 4.5 million people in United States. 100,000 people die of AD every year, nevertheless hundred years have been passed after the discovery of AD but the appropriate pathology was not yet determined only it still floats in the hypotheses in contrast to the inventions in the medicine so far, hypothesis like amyloid cascades, neurofibrillary tangles, are well established but with incomplete benefits from them, in recent days the role of estrogen, cholesterol are also being included in AD pathology. Treatment lines are following just to improve the dementia but not able to concentrate in to the pathology, all these made the AD in to an ambiguous disease which is yet to be explored a lot as early as possible for the well-being of the sufferers and to ameliorate their disabilities

 

Keywords: Alzheimer Disease, ambiguous disease, Apolipoprotein E, amyloid cascades, neurofibrillary tangles

 

Downloads

Published

2019-07-11

Issue

Vol. 5 No. 3 (2014)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.